© 2020 Texas Public Radio
Real. Reliable. Texas Public Radio.
Play Live Radio
Next Up:
Available On Air Stations
TPR Events & Initiatives
00000174-b11b-ddc3-a1fc-bfdbb1d30001HearSA is an online audio archive of public programming intended to foster discussion and enhance awareness of exciting and informative local presentations and events. The HearSA archive includes lectures, panel discussions, book readings, and much more. Texas Public Radio partners with local organizations to bring a second life online to the most interesting talks in town. Content from HearSA may be selected by Texas Public Radio for broadcast or on-air commentary, providing further exposure for archived program material.HearSA is presented by Texas Public Radio in association with its local partners. It is important to recognize that the opinions presented in these programs are those of the author or presenter, not Texas Public Radio or any of its stations, and are not necessarily endorsed by TPR.If your organization hosts lectures, book readings, panel discussions, or presentations and is interested in participating, email HearSA curator, Nathan Cone at ncone [at] tpr dot org

Think Health Science: Clinical Trials at the Cancer Therapy & Research Center


A group of researchers at the University of Texas Health Science Center at San Antonio have developed a way to deliver nanoparticle radiation directly to the brain tumor and keep it there. The method doses the tumor itself with much higher levels of radiation, twenty to thirty times the current dose of radiation therapy to patients, but spares a much greater area of brain tissue. 

To speak on the latest development is Andrew Brenner, M.D., Ph.D., of the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center. Watch the entire presentation at this link or use the audio player below to download or listen.


Andrew Brenner, M.D. 

Andrew Brenner, M.D., Ph.D., of the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center, is a specialist in both breast cancer and malignancies of the brain and spinal cord. Dr. Brenner focuses not only on clinical management, but also on the development of novel therapies to treat these cancers. At the CTRC, he is extensively involved in clinical trials that make new treatments available to South Texas patients. this included a first-in-man study of a new radiation treatment implanted in the center of a patient's brain tumor called a glioblastoma. Dr. Brenner earned his bachelor's degree in biochemistry at Texas A&M Univeristy and went on to earn his doctorate in biological science and tumor biology at The University of Texas M.D. Anderson Cancer Center - Science Park. Dr. Brenner received his medical degree from the Texas Tech University Health Sciences Center and completed a residency in internal medicine at Scott and White Hospital in Lubbock. He completed his fellowship in hematology and medical oncology at the UT Health Science Center.